The laboratory of Dr. Moldoneavu centers on utilizing structural and biochemical approaches to understand the mechanisms of programmed cell death including apoptosis, necroptosis, and ferroptosis particularly in myeloma.
Ren Xu, Ph.D.
Brenda Gannon, Ph.D.
Yunmeng Liu, Ph.D.
Amit K. Tiwari, Ph.D., D.A.B.T
Tudor Moldoneavu, Ph.D.
Dan Dixon, Ph.D.
Sanja Novak, Ph.D.
Tuhin Virmani, M.D., Ph.D.
The research interests of the Virmani laboratory are: 1) the development of predictive algorithms for disease progression in Parkinson’s disease with Freezing of Gait as a model system; 2) the development of treatments for Freezing of Gait; 3) improving care delivery (such as through a hub-and-spoke model of clinical care) and increasing research participation for […]
Mokarram Hossain, PhD
My laboratory develops novel immunotherapies for rare solid tumors and inflammatory conditions. We engineer therapeutic antibodies with two key goals: harnessing immune cells’ natural ability to destroy cancer and blocking specific receptors to control inflammation. Our mission is to advance these novel treatments to the clinic, particularly focusing on rare disease patients who have limited […]